Glaukos Corporation (GKOS)
NYSE · Healthcare
Glaukos Corporation Shareholder Equity 2013–2025
Glaukos Corporation annual shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Glaukos Corporation shareholder equity as of December 31, 2025: 656.2M, a 14.44% decrease year-over-year.
- Glaukos Corporation shareholder equity for 2025 were 656.2M, a 14.44% decrease from 2024.
- Glaukos Corporation shareholder equity for 2024 were 766.9M, a 66.09% increase from 2023.
- Glaukos Corporation shareholder equity for 2023 were 461.8M, a 12.88% decrease from 2022.
- Glaukos Corporation shareholder equity for 2022 were 530.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Glaukos Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $656 |
| 2024 | $767 |
| 2023 | $462 |
| 2022 | $530 |
| 2021 | $587 |
| 2020 | $667 |
| 2019 | $673 |
| 2018 | $174 |
| 2017 | $138 |
| 2016 | $117 |
| 2015 | $95 |
| 2014 | $-151 |
Glaukos Corporation Shareholder Equity — FAQ
Glaukos Corporation (GKOS) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GKOS's shareholder equity history?
The chart and table above show Glaukos Corporation's shareholder equity by year and by quarter, including the growth rate.